Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 April 2021 | Story Rulanzen Martin | Photo Supplied
Dr Munyaradzi Mushonga drew from Moshoeshoe I’s decolonial philosophy in his virtual lecture hosted by Institute of Peace and Leadership at the National University of Lesotho.

King Moshoeshoe I was a decolonial philosopher-king well before the decolonisation of the 20th century and the current insurgent and resurgent decolonial turn gained momentum. This was the overarching message of Dr Munyaradzi Mushonga, who delivered the annual Moshoeshoe I Memorial lecture. The lecture, hosted by the Moshoeshoe I Institute of Peace and Leadership at the National University of Lesotho, took place virtually on Wednesday 17 March 2021.

Dr Mushonga, Senior Lecturer and Progamme Director of Africa Studies in the Centre for Gender and Africa Studies (CGAS) at the University of the Free State, says his lecture titled, In living memory of Moshoeshoe I: The decolonial philosopher-king of love, peace, co-existence and pluriversal humanism, was about how wisdom, knowledge, love, peace, ethics of living together, and pluriversal humanism were all merged into alliance in the one person of King Moshoeshoe.  

Moshoehoeism a prequel for modern decolonialism 

Being an African Studies scholar, Dr Mushonga implored modern scholars to appreciate ‘Moshoehoeism’ and said that such lectures provide the opportunity to relive the past and honour prominent individuals such as King Moshoeshoe I.

Moshoehoeism is a philosophy that is dedicated to liberating Frantz Fanon’s ‘the wretched of the earth’. It is important that Moshoehoeism is used by African Studies scholars for the “purposes of re-humanising, remembering, and re-educating previously de-humanised, dis-membered and mis-educated sons and daughters of the earth.” 

Dr Mushongha says that King Moshoeshoe I was always seeking true understanding (knowledge) – to seek true knowledge is to have a decolonial mind and consciousness. “He saved his kingdom from extinction through a paradigm of knowledge; a paradigm that informed him that it was time to make concessions on sovereignty in order to save the nation and nationhood.”

“To have the wisdom, knowledge, and courage to love and make peace under social and political conditions that did not permit love and peace is to be truly decolonial,” said Dr Mushongha. 

WATCH: YouTube recording of Moshoeshoe I Memorial Lecture 

Note to viewers: the order of the recordings is as follows:
1. Preamble
2. Part 1
3. Part 2a
4. Part 2b
5. Part 3 and 4

 


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept